Results 161 to 170 of about 23,101 (249)

High-throughput cloning reveals diverse properties of T-cell receptors targeting minor histocompatibility antigens. [PDF]

Blood Adv
Ito S, Martin E, Panousis C, Rowe AM, Stras S, Roy J, Cofano EB, Ventura K, Parr K, Neupane B, Bellesis A, Toki A, Jing R, Jang J, Neves AT, Shlomchik MJ, Shlomchik WD.   +16 more
europepmc   +1 more source

Discovery of minor histocompatibility antigens as targets for immunotherapy

, 2016
Allogeneic stem cell transplantation (alloSCT) can be a curative treatment for hematological malignancies. However, the desired anti-tumor or Graft-versus-Leukemia (GvL) effect is often accompanied by undesired side effects, a ...
Pont, M.J.
core  

Efficacy of Multimodal Work‐Up of Head and Neck Squamous Cell Carcinoma Lymph Node Metastasis of Unknown Primary

Head &Neck, Volume 48, Issue 6, Page 1426-1436, June 2026.
ABSTRACT Background Head and neck squamous cell carcinoma (HNSCC) often presents with cervical lymph node metastasis, with 1%–4% of cases presenting as cancer of unknown primary (CUP). CUP poses diagnostic and therapeutic challenges and is linked to poorer survival outcomes.
Robin W. Jansen, Roland M. Martens, Obaida Abdulrahman, Laura Peferoen, C. René Leemans, Gerben J. C. Zwezerijnen, Jan‐Jaap Hendrickx, Pim de Graaf   +7 more
wiley   +1 more source

AlloPipe and Its Web Server Allogenomics: From Genomic Data to Candidate Minor Histocompatibility Antigens. [PDF]

HLA
Dhuyser A, Delaugère P, Laville P, Clerc R, Aarnink A, Mesnard L, Richard H.   +6 more
europepmc   +1 more source

New strategies in identification and quantification of minor histocompatibility antigens

, 2015
The involvement of Minor histocompatibility antigens (MiHA) in the graft versus tumor is described about three decades ago. Nowadays, there are many evidences that, after HLA-matched allogeneic hematopoietic stem cell transplantation (HSCT) MiHA specific
Hassan, C.
core  

Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation. [PDF]

Nat Biotechnol
Cieri N, Hookeri N, Stromhaug K, Li L, Keating J, Díaz-Fernández P, Gómez-García de Soria V, Stevens J, Kfuri-Rubens R, Shao Y, Kooshesh KA, Powell K, Ji H, Hernandez GM, Abelin J, Klaeger S, Forman C, Clauser KR, Sarkizova S, Braun DA, Penter L, Kim HT, Lane WJ, Oliveira G, Kean LS, Li S, Livak KJ, Carr SA, Keskin DB, Muñoz-Calleja C, Ho VT, Ritz J, Soiffer RJ, Neuberg D, Stewart C, Getz G, Wu CJ.   +36 more
europepmc   +1 more source

Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens. [PDF]

Transfus Med Rev, 2013
Patel SR, Zimring JC.
europepmc   +1 more source

A new minor histocompatibility locus linked to H-3.

, 1981
B10, BALB.B, and A.BY shared an allele at a new locus not shared by B10.LP-H-3b. This locus is linked to the minor histocompatibility gene, H-3, in the 5th linkage group of chromosome 2 of the mouse.
Click, R E, Schneider, D, Roopenian, D C
core  

Human Papillomavirus: Update in Bridging Basic Science to Clinical and Public Health Innovations

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Human papillomavirus (HPV), a non‐enveloped, double‐strand DNA viral pathogen, is intricately linked with the onset of various cancers, including cervical cancer and head and neck cancers. The present paper delves into HPV's ancient recognition and significant milestones such as the discovery of its role in oncogenesis and the development of ...
Fatemeh Beygnejad, Narges Eslami, Kaveh Gharaei Nejad, Atefeh Zamani Kermanshahi, Hossein Bannazadeh Baghi   +4 more
wiley   +1 more source

S232: EXPANDING THE REPERTOIRE OF HLA CLASS I-RESTRICTED MINOR HISTOCOMPATIBILITY ANTIGENS FOR IMMUNE MONITORING AND MODULATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

HemaSphere, 2022
K. Fuchs, M. van de Meent, W. Honders, C. van Bergen, J. F. Falkenburg, M. Griffioen   +5 more
doaj   +1 more source